TrianglePUBLICATIONS · 35947804
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2022 Oct 1
- First author
- Morschhauser F
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Morschhauser F
- type
- Author
- name
- Nastoupil L
- type
- Author
- name
- Feugier P
- type
- Author
- name
- Schiano de Colella JM
- type
- Author
- name
- Tilly H
- type
- Author
- name
- Palomba ML
- type
- Author
- name
- Bachy E
- type
- Author
- name
- Fruchart C
- type
- Author
- name
- Libby EN
- type
- Author
- name
- Casasnovas RO
- type
- Author
- name
- Flinn IW
- type
- Author
- name
- Haioun C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Morschhauser F
- type
- Author
- name
- Nastoupil L
- type
- Author
- name
- Feugier P
- type
- Author
- name
- Schiano de Colella JM
- type
- Author
- name
- Tilly H
- type
- Author
- name
- Palomba ML
- type
- Author
- name
- Bachy E
- type
- Author
- name
- Fruchart C
- type
- Author
- name
- Libby EN
- type
- Author
- name
- Casasnovas RO
- type
- Author
- name
- Flinn IW
- type
- Author
- name
- Haioun C
- type
- Author
- bibliography ids
- nci-bib-523009a58beb8c91d69472b0
- book metadata
- content sha256
- 40edcc5141548a3e909f4c26e468a7952dedc450e9a36b6c5c4775440e283201
- document type
- citation
- dois
- 10.1200/JCO.22.00843
- electronic publication date
- display
- 2022 Aug 10
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35947804
- immutable id
- pubmed:35947804@40edcc5141548a3e909f4c26e468a7952dedc450e9a36b6c5c4775440e283201
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 28
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3239-3245
- volume
- 40
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35947804
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- b3fc1d4abb6201dc9d1d281cabc87aed8ef870ef62f3568867250deb441d485e
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2022 Oct 1
- precision
- day
- year
- 2022
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma.
Preserved source evidence · Independent clinical review pending · Not medical advice